Surat Kepada WHO

 

Cirebon, Indonesia
24 08 / 08
For the officer of
World Health Organization
(WHO)
In place

God bless us sir,
I think it is the time for you to change the policy about dengue hemorrhagic fever. Policy or we can say the instruction for all of elements of health organization in every country in the worlds and of course for all the faculty of medicine to change the way of therapy in dengue hemorrhagic fever. This point is based on the reality that this theory hypersensitivity type III is the STRONGEST for describing pathogenesis and pathophysiology dengue hemorrhagic fever.

We both know that the dead of dengue hemorrhagic fever is small only 1-2 percent from the sufferer of DHF, but this accident happen on thousand of people and all of you must pay for that ! In the opposite, the dead of adult DHF in the Waled hospital in Cirebon, Indonesia is only ZERO (0) percent in last ten years.
In the end I hope Allah reveal His love for us all. Amen.

By : Dr. Taufiq M. Waly
E – mail : taufiqmw@yahoo.com
Addres : Kampung Melati st number 10G Kesambi,
Cirebon, West Java, Indonesia

 

WHO SAID :

Bapak Dr. Taufiq yth,

Terima kasih atas email anda kepada kami, segala informasi dan kritik anda akan menjadi masukan kepada WHO yang selanjutnya akan disampaikan kepada Subdirektorat Arbovirosis di Direktorat Pemberantasan penyakit bersumber binatang Direktorat Jenderal Pengendalian Penyakit dan Kesehatan Lingkungan maupun pihak-pihak lainnya di WHO.

Salam hormat,

Muhammad Asri Amin

NPO- Malaria dan penyakit bersumber binatang

WHO- Indonesia

 

2ND Command

Assalamu`alaikum Wr Wb,
Kepada Yth : Dr.Taufiq Wally SpPD
RS.Walet Cirebon

Selamat Bang atas Blog DHFnya, sayang kalau memang kita tidak peduli masalah ini, kasus DHF selalu ada dan selalu menyebabkan kematian. Tampaknya kita semua tidak peduli bahwa penyakit yang seharusnya bisa dikendalikan ini tidak bisa dsembuhkan. Informasi Bang Taufik bahwa dalam 10 tahun terakhir angka mortalitas DHF 0 di RS.Walet Cirebon merupakan bukti sebenarnya penyakit ini tidak seganas yang kita duga kalau ditangani dengan baik.Boleh juga data lengkap mengenai hal ini dapat dipublikasi pada blog ini. Tips dan triknya juga bisa dishare dengan yang lain.

Sukses Bang dan jangan pernah mundur dari Visi dan MIsi yang hebat ini.

Wassalam

Ari Fahrial Syam

(Peminat Masalah DHF)

Afankelijkheid said

Thank you for your attention and for your support to my blog. Blog that I have made to change the basic of pathophysiology and pathogenesis of DHF. Which I have said in the first time that the basic of hipersensitivity type III which has variation of thrombocyte antibody positive in my research. Because I consider the basic of pathogenesis and pathophysiology in DHF is Hipersensitivity reaction type III with variation of thrombocyte antibody so, it has been a must for us to give the steroid to DHF patient. Steroid always be given to DHF patient with fever <5 days if the thrombocytes are <100.000/mm3 or if thrombocyte decreasing so fast in monitoring thrombocyte count. For example, in three times examination, count of thrombocyte decreased from 200.000 to 150.000 and then down to 120.000. For DHF patient with fever 5 days or more steroid should be given if thrombocyte shows a decreation trend in monitoring count of thrombocyte or if the thrombocyte decreasing faster (>50.000/mm3) in monitoring. It is the best if we give the steroid when thromboyte antibody has been proven as positive. Contra indication to give steroid if the patient have gastrointestinal bleeding. Cortico steroid immunosupressif didn’t only pushed thrombocytopenia but all of the immunologist reaction that happened in DHF. By the way, DHF will not becoming more worse. That’s the trick which has been causing the dead of DHF patient in Waled Hospital is zero percent in the last ten years. Answer like this has informed too to a Harvard University professor. And I have discussed my theory with our teacher, Professor Daldiono. Our sincerest gratitude from me to him.
God bless you and your family, amen.

Leave a Reply

Your email address will not be published. Required fields are marked *